位置:首页 > 蛋白库 > MDM1_HUMAN
MDM1_HUMAN
ID   MDM1_HUMAN              Reviewed;         714 AA.
AC   Q8TC05; B4DM65; E7EPQ3; O43406; Q8WTV9; Q9NR04;
DT   21-AUG-2007, integrated into UniProtKB/Swiss-Prot.
DT   21-AUG-2007, sequence version 2.
DT   03-AUG-2022, entry version 139.
DE   RecName: Full=Nuclear protein MDM1;
GN   Name=MDM1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RA   Yang Q.S., Ying K., Wu H., Xia F., Xie Y., Mao Y.M.;
RT   "Cloning, mapping and characterization of a novel human MDM1 protein.";
RL   Submitted (MAY-2000) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4).
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M., Kovar-Smith C.,
RA   Lewis L.R., Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R.,
RA   Montgomery K.T., Morgan M.B., Nazareth L.V., Scott G., Sodergren E.,
RA   Song X.-Z., Steffen D., Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y.,
RA   Zhang Z., Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G.,
RA   Chen Z., Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H.,
RA   Draper H., Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S.,
RA   Kelly S.H., Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M.,
RA   Nguyen B.-V., Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H.,
RA   Santibanez J., Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q.,
RA   Williams G.A., Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V.,
RA   Bailey M., Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E.,
RA   Burkett C.E., Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M., Dathorne S.R.,
RA   David R., Davis C.M., Davy-Carroll L., Deshazo D.R., Donlin J.E.,
RA   D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J., Escotto M., Flagg N.,
RA   Forbes L.D., Gabisi A.M., Garza M., Hamilton C., Henderson N.,
RA   Hernandez O., Hines S., Hogues M.E., Huang M., Idlebird D.G., Johnson R.,
RA   Jolivet A., Jones S., Kagan R., King L.M., Leal B., Lebow H., Lee S.,
RA   LeVan J.M., Lewis L.C., London P., Lorensuhewa L.M., Loulseged H.,
RA   Lovett D.A., Lucier A., Lucier R.L., Ma J., Madu R.C., Mapua P.,
RA   Martindale A.D., Martinez E., Massey E., Mawhiney S., Meador M.G.,
RA   Mendez S., Mercado C., Mercado I.C., Merritt C.E., Miner Z.L., Minja E.,
RA   Mitchell T., Mohabbat F., Mohabbat K., Montgomery B., Moore N., Morris S.,
RA   Munidasa M., Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O.,
RA   Nwokenkwo S., Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D., Trejos Z.Y.,
RA   Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I., Vera V.A.,
RA   Villasana D.M., Wang L., Ward-Moore S., Warren J.T., Wei X., White F.,
RA   Williamson A.L., Wleczyk R., Wooden H.S., Wooden S.H., Yen J., Yoon L.,
RA   Yoon V., Zorrilla S.E., Nelson D., Kucherlapati R., Weinstock G.,
RA   Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3), AND VARIANTS
RP   ILE-103; HIS-489 AND LEU-552.
RC   TISSUE=Prostate, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 462-714 (ISOFORM 1), AND VARIANT
RP   HIS-489.
RC   TISSUE=Brain;
RA   Yu W., Sarginson J., Gibbs R.A.;
RL   Submitted (JUN-1997) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY, AND SUBCELLULAR LOCATION [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Lymphoblast;
RX   PubMed=14654843; DOI=10.1038/nature02166;
RA   Andersen J.S., Wilkinson C.J., Mayor T., Mortensen P., Nigg E.A., Mann M.;
RT   "Proteomic characterization of the human centrosome by protein correlation
RT   profiling.";
RL   Nature 426:570-574(2003).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-242; SER-263; SER-584 AND
RP   SER-648, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-83, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [9]
RP   FUNCTION, SUBCELLULAR LOCATION, DOMAIN [ST]-E-Y-X(3)-F MOTIF, AND
RP   MUTAGENESIS OF 9-SER--PHE-15; 189-SER--PHE-195; 232-THR--PHE-238 AND
RP   306-SER--PHE-312.
RX   PubMed=26337392; DOI=10.1091/mbc.e15-04-0235;
RA   Van de Mark D., Kong D., Loncarek J., Stearns T.;
RT   "MDM1 is a microtubule-binding protein that negatively regulates centriole
RT   duplication.";
RL   Mol. Biol. Cell 26:3788-3802(2015).
CC   -!- FUNCTION: Microtubule-binding protein that negatively regulates
CC       centriole duplication. Binds to and stabilizes microtubules
CC       (PubMed:26337392). {ECO:0000269|PubMed:26337392}.
CC   -!- INTERACTION:
CC       Q8TC05; Q2TAC2-2: CCDC57; NbExp=3; IntAct=EBI-3951677, EBI-10961624;
CC       Q8TC05; Q9NSC5: HOMER3; NbExp=3; IntAct=EBI-3951677, EBI-748420;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:26337392}. Cytoplasm,
CC       cytoskeleton, microtubule organizing center, centrosome
CC       {ECO:0000269|PubMed:14654843, ECO:0000269|PubMed:26337392}. Cytoplasm,
CC       cytoskeleton, microtubule organizing center, centrosome, centriole
CC       {ECO:0000269|PubMed:26337392}. Note=Localizes to the centriole lumen.
CC       {ECO:0000269|PubMed:26337392}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q8TC05-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8TC05-2; Sequence=VSP_027546, VSP_027547;
CC       Name=3;
CC         IsoId=Q8TC05-3; Sequence=VSP_027544, VSP_027545;
CC       Name=4;
CC         IsoId=Q8TC05-4; Sequence=VSP_046400, VSP_046401;
CC   -!- SIMILARITY: Belongs to the MDM1 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF267851; AAF78952.1; -; mRNA.
DR   EMBL; AK297311; BAG59777.1; -; mRNA.
DR   EMBL; AC022511; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC022042; AAH22042.1; -; mRNA.
DR   EMBL; BC028355; AAH28355.1; -; mRNA.
DR   EMBL; AF007130; AAC19149.1; -; mRNA.
DR   CCDS; CCDS44938.1; -. [Q8TC05-2]
DR   CCDS; CCDS55841.1; -. [Q8TC05-4]
DR   CCDS; CCDS55842.1; -. [Q8TC05-3]
DR   CCDS; CCDS8983.1; -. [Q8TC05-1]
DR   RefSeq; NP_001191957.1; NM_001205028.1. [Q8TC05-4]
DR   RefSeq; NP_001191958.1; NM_001205029.1. [Q8TC05-3]
DR   RefSeq; NP_059136.2; NM_017440.4. [Q8TC05-1]
DR   RefSeq; NP_064513.1; NM_020128.2. [Q8TC05-2]
DR   AlphaFoldDB; Q8TC05; -.
DR   BioGRID; 121220; 9.
DR   IntAct; Q8TC05; 7.
DR   STRING; 9606.ENSP00000302537; -.
DR   iPTMnet; Q8TC05; -.
DR   PhosphoSitePlus; Q8TC05; -.
DR   BioMuta; MDM1; -.
DR   DMDM; 156632525; -.
DR   EPD; Q8TC05; -.
DR   jPOST; Q8TC05; -.
DR   MassIVE; Q8TC05; -.
DR   MaxQB; Q8TC05; -.
DR   PaxDb; Q8TC05; -.
DR   PeptideAtlas; Q8TC05; -.
DR   PRIDE; Q8TC05; -.
DR   ProteomicsDB; 17412; -.
DR   ProteomicsDB; 74064; -. [Q8TC05-1]
DR   ProteomicsDB; 74065; -. [Q8TC05-2]
DR   ProteomicsDB; 74066; -. [Q8TC05-3]
DR   Antibodypedia; 29303; 135 antibodies from 24 providers.
DR   DNASU; 56890; -.
DR   Ensembl; ENST00000303145.11; ENSP00000302537.7; ENSG00000111554.15. [Q8TC05-1]
DR   Ensembl; ENST00000393543.7; ENSP00000377175.3; ENSG00000111554.15. [Q8TC05-3]
DR   Ensembl; ENST00000411698.6; ENSP00000391006.2; ENSG00000111554.15. [Q8TC05-4]
DR   Ensembl; ENST00000430606.3; ENSP00000408694.2; ENSG00000111554.15. [Q8TC05-2]
DR   GeneID; 56890; -.
DR   KEGG; hsa:56890; -.
DR   UCSC; uc001stz.3; human. [Q8TC05-1]
DR   CTD; 56890; -.
DR   DisGeNET; 56890; -.
DR   GeneCards; MDM1; -.
DR   HGNC; HGNC:29917; MDM1.
DR   HPA; ENSG00000111554; Low tissue specificity.
DR   MIM; 613813; gene.
DR   neXtProt; NX_Q8TC05; -.
DR   OpenTargets; ENSG00000111554; -.
DR   PharmGKB; PA134879752; -.
DR   VEuPathDB; HostDB:ENSG00000111554; -.
DR   eggNOG; ENOG502QVRV; Eukaryota.
DR   GeneTree; ENSGT00390000004106; -.
DR   HOGENOM; CLU_023835_0_0_1; -.
DR   InParanoid; Q8TC05; -.
DR   OMA; KVNTEYR; -.
DR   OrthoDB; 350018at2759; -.
DR   PhylomeDB; Q8TC05; -.
DR   TreeFam; TF331015; -.
DR   PathwayCommons; Q8TC05; -.
DR   SignaLink; Q8TC05; -.
DR   BioGRID-ORCS; 56890; 14 hits in 1083 CRISPR screens.
DR   ChiTaRS; MDM1; human.
DR   GenomeRNAi; 56890; -.
DR   Pharos; Q8TC05; Tbio.
DR   PRO; PR:Q8TC05; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   RNAct; Q8TC05; protein.
DR   Bgee; ENSG00000111554; Expressed in bronchial epithelial cell and 190 other tissues.
DR   ExpressionAtlas; Q8TC05; baseline and differential.
DR   Genevisible; Q8TC05; HS.
DR   GO; GO:0034451; C:centriolar satellite; IDA:HPA.
DR   GO; GO:0005814; C:centriole; IDA:UniProtKB.
DR   GO; GO:0005813; C:centrosome; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005874; C:microtubule; IEA:UniProtKB-KW.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0008017; F:microtubule binding; IMP:UniProtKB.
DR   GO; GO:0046600; P:negative regulation of centriole replication; IMP:UniProtKB.
DR   GO; GO:0060041; P:retina development in camera-type eye; IBA:GO_Central.
DR   InterPro; IPR029136; MDM1.
DR   PANTHER; PTHR32078; PTHR32078; 1.
DR   Pfam; PF15501; MDM1; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cytoplasm; Cytoskeleton; Microtubule; Nucleus;
KW   Phosphoprotein; Reference proteome.
FT   CHAIN           1..714
FT                   /note="Nuclear protein MDM1"
FT                   /id="PRO_0000299059"
FT   REGION          79..152
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          391..571
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          616..637
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           9..15
FT                   /note="ST]-E-Y-X(3)-F motif 1; required for efficient
FT                   microtubule binding and stabilization"
FT                   /evidence="ECO:0000269|PubMed:26337392"
FT   MOTIF           189..195
FT                   /note="ST]-E-Y-X(3)-F motif 2; required for efficient
FT                   microtubule binding and stabilization"
FT                   /evidence="ECO:0000269|PubMed:26337392"
FT   MOTIF           232..238
FT                   /note="ST]-E-Y-X(3)-F motif 3; required for efficient
FT                   microtubule binding and stabilization"
FT                   /evidence="ECO:0000269|PubMed:26337392"
FT   MOTIF           306..312
FT                   /note="ST]-E-Y-X(3)-F motif 4; required for efficient
FT                   microtubule binding and stabilization"
FT                   /evidence="ECO:0000269|PubMed:26337392"
FT   COMPBIAS        91..132
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        135..152
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        444..460
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        469..505
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        550..571
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        619..637
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         83
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         123
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9D067"
FT   MOD_RES         126
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9D067"
FT   MOD_RES         242
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         263
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         314
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9D067"
FT   MOD_RES         560
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9D067"
FT   MOD_RES         584
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         648
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   VAR_SEQ         46..69
FT                   /note="ITKEPSFISKRRVPYHDPQISKSL -> NQGRCRTKIQHSDISSLLILVCST
FT                   (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_027544"
FT   VAR_SEQ         70..714
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_027545"
FT   VAR_SEQ         167..222
FT                   /note="LDRLLRKKAGLTVVPSYNALRNSEYQRQFVWKTSKETAPAFAANQVFHNKSQ
FT                   FVPP -> VGIFTAFLFKSIEFFIGFIVISVILHFVFQNFPLLFSCLMSIRIVDNRLLT
FT                   LVIVN (in isoform 2)"
FT                   /evidence="ECO:0000303|Ref.1"
FT                   /id="VSP_027546"
FT   VAR_SEQ         167..211
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_046400"
FT   VAR_SEQ         223..714
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|Ref.1"
FT                   /id="VSP_027547"
FT   VAR_SEQ         335
FT                   /note="Q -> QGSLNAMWYAE (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_046401"
FT   VARIANT         103
FT                   /note="T -> I (in dbSNP:rs962976)"
FT                   /evidence="ECO:0000269|PubMed:15489334"
FT                   /id="VAR_034782"
FT   VARIANT         383
FT                   /note="V -> I (in dbSNP:rs17224810)"
FT                   /id="VAR_034783"
FT   VARIANT         489
FT                   /note="R -> H (in dbSNP:rs2306393)"
FT                   /evidence="ECO:0000269|PubMed:15489334, ECO:0000269|Ref.5"
FT                   /id="VAR_034784"
FT   VARIANT         552
FT                   /note="P -> L (in dbSNP:rs2306392)"
FT                   /evidence="ECO:0000269|PubMed:15489334"
FT                   /id="VAR_034785"
FT   MUTAGEN         9..15
FT                   /note="SEYQRNF->AAAQRNA: Loss of microtubule binding, no
FT                   loss of centrosomal localization, little effect on
FT                   microtubule stability, loss of ability to block centriole
FT                   reduplication and defective blocking of normal centriole
FT                   duplication; when associated with 189-A--A-195; 232-A--A-
FT                   238 and 306-A--A-312."
FT   MUTAGEN         189..195
FT                   /note="SEYQRQF->AAAQRQA: Loss of microtubule binding, no
FT                   loss of centrosomal localization, little effect on
FT                   microtubule stability, loss of ability to block centriole
FT                   reduplication and defective blocking of normal centriole
FT                   duplication; when associated with 9-A--A-15; 232-A--A-238
FT                   and 306-A--A-312."
FT   MUTAGEN         232..238
FT                   /note="TEYKRNF->AAAKRNA: Loss of microtubule binding, no
FT                   loss of centrosomal localization, little effect on
FT                   microtubule stability, loss of ability to block centriole
FT                   reduplication and defective blocking of normal centriole
FT                   duplication; when associated with 9-A--A-15; 189-A--A-195
FT                   and 306-A--A-312."
FT   MUTAGEN         306..312
FT                   /note="SEYRAKF->AAARAKA: Loss of microtubule binding, no
FT                   loss of centrosomal localization, little effect on
FT                   microtubule stability, loss of ability to block centriole
FT                   reduplication and defective blocking of normal centriole
FT                   duplication; when associated with 9-A--A-15; 189-A--A-195
FT                   and 232-A--A-238."
FT   CONFLICT        42
FT                   /note="D -> Y (in Ref. 2; BAG59777)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        458
FT                   /note="G -> E (in Ref. 2; BAG59777)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   714 AA;  80735 MW;  301E3A89A5BFF13B CRC64;
     MPVRFKGLSE YQRNFLWKKS YLSESCNSSV GRKYPWAGLR SDQLGITKEP SFISKRRVPY
     HDPQISKSLE WNGAISESNV VASPEPEAPE TPKSQEAEQK DVTQERVHSL EASRVPKRTR
     SHSADSRAEG ASDVENNEGV TNHTPVNENV ELEHSTKVLS ENVDNGLDRL LRKKAGLTVV
     PSYNALRNSE YQRQFVWKTS KETAPAFAAN QVFHNKSQFV PPFKGNSVIH ETEYKRNFKG
     LSPVKEPKLR NDLRENRNLE TVSPERKSNK IDDRLKLEAE MELKDLHQPK RKLTPWKHQR
     LGKVNSEYRA KFLSPAQYLY KAGAWTHVKG NMPNQVKELR EKAEFYRKRV QGTHFSRDHL
     NQILSDSNCC WDVSSTTSSE GTVSSNIRAL DLAGDPTSHK TLQKCPSTEP EEKGNIVEEQ
     PQKNTTEKLG VSAPTIPVRR RLAWDTENTS EDVQKQPGEK EEEDDNEEEG DRKTGKQAFM
     GEQEKLDVRE KSKADKMKEG SDSSVSSEKG GRLPTPKLRE LGGIQRTHHD LTTPAVGGAV
     LVSPSKMKPP APEQRKRMTS QDCLETSKND FTKKESRAVS LLTSPAAGIK TVDPLPLRED
     SEDNIHKFAE ATLPVSKIPK YPTNPPGQLP SPPHVPSYWH PSRRIQGSLR DPEFQHNVGK
     ARMNNLQLPQ HEAFNDEDED RLSEISARSA ASSLRAFQTL ARAKKRKENF WGKT
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024